David T Hsieh1, Susan L Whiteway1, Luis O Rohena1, Elizabeth A Thiele1. 1. Divisions of Child Neurology (DTH), Hematology/Oncology (SLW), and Medical Genetics (LOR), Department of Pediatrics, San Antonio Military Medical Center, JBSA - Ft. Sam Houston, TX; and Pediatric Epilepsy Program (EAT), Department of Neurology, Massachusetts General Hospital, Boston.
Abstract
PURPOSE OF REVIEW: Tuberous sclerosis complex (TSC) is a variably expressed neurocutaneous genetic disorder characterized by hamartomatous growths in multiple organ systems. Neurologic involvement often confers the most severe symptoms, and can include epilepsy, increased intracranial pressure from hydrocephalus, intellectual deficits, and autism. The purpose of this review is to provide a neurologically focused update in the diagnosis and treatment of these complications in patients with TSC. RECENT FINDINGS: We highlight 5 new areas of understanding in TSC: the neurobiology of TSC and its translation into clinical practice, vigabatrin in the treatment of infantile spasms, the role of tubers and epilepsy surgery, the treatment of subependymal giant cell astrocytomas, and TSC-related neuropsychiatric disorders. SUMMARY: These recent advances in diagnosis and treatment give our patients with TSC and their families hope for the future for improved care and possible preventive cures, to the end goal of improving quality of life.
PURPOSE OF REVIEW: Tuberous sclerosis complex (TSC) is a variably expressed neurocutaneous genetic disorder characterized by hamartomatous growths in multiple organ systems. Neurologic involvement often confers the most severe symptoms, and can include epilepsy, increased intracranial pressure from hydrocephalus, intellectual deficits, and autism. The purpose of this review is to provide a neurologically focused update in the diagnosis and treatment of these complications in patients with TSC. RECENT FINDINGS: We highlight 5 new areas of understanding in TSC: the neurobiology of TSC and its translation into clinical practice, vigabatrin in the treatment of infantile spasms, the role of tubers and epilepsy surgery, the treatment of subependymal giant cell astrocytomas, and TSC-related neuropsychiatric disorders. SUMMARY: These recent advances in diagnosis and treatment give our patients with TSC and their families hope for the future for improved care and possible preventive cures, to the end goal of improving quality of life.
Authors: Deepak Madhavan; Sarah Schaffer; Alexei Yankovsky; Alexis Arzimanoglou; Florence Renaldo; Charles M Zaroff; Josiane LaJoie; Howard L Weiner; Eva Andermann; David N Franz; Jennifer Leonard; Mary Connolly; Greg D Cascino; Orrin Devinsky Journal: Epilepsia Date: 2007-05-01 Impact factor: 5.864
Authors: F E Jansen; K L Vincken; A Algra; P Anbeek; O Braams; M Nellist; B A Zonnenberg; A Jennekens-Schinkel; A van den Ouweland; D Halley; A C van Huffelen; O van Nieuwenhuizen Journal: Neurology Date: 2007-11-21 Impact factor: 9.910
Authors: Ahmad R Mohamed; Catherine A Bailey; Jeremy L Freeman; Wirginia Maixner; Graeme D Jackson; A Simon Harvey Journal: Neurology Date: 2012-11-21 Impact factor: 9.910
Authors: Jonathan Roth; E Steve Roach; Ute Bartels; Sergiusz Jóźwiak; Mary Kay Koenig; Howard L Weiner; David N Franz; Henry Z Wang Journal: Pediatr Neurol Date: 2013-10-15 Impact factor: 3.372
Authors: Carol A Westall; Tom Wright; Filomeno Cortese; Ananthavalli Kumarappah; O Carter Snead; Joseph R Buncic Journal: Neurology Date: 2014-11-07 Impact factor: 9.910
Authors: Magdalena E Tyburczy; Kira A Dies; Jennifer Glass; Susana Camposano; Yvonne Chekaluk; Aaron R Thorner; Ling Lin; Darcy Krueger; David N Franz; Elizabeth A Thiele; Mustafa Sahin; David J Kwiatkowski Journal: PLoS Genet Date: 2015-11-05 Impact factor: 5.917
Authors: Shu-Ichi Okamoto; Olga Prikhodko; Juan Pina-Crespo; Anthony Adame; Scott R McKercher; Laurence M Brill; Nobuki Nakanishi; Chang-Ki Oh; Tomohiro Nakamura; Eliezer Masliah; Stuart A Lipton Journal: Neurobiol Dis Date: 2019-03-27 Impact factor: 5.996